PERGOLIDE AND LISURIDE FOR PARKINSON'S DISEASE
- 24 November 1979
- journal article
- other
- Published by Elsevier in The Lancet
- Vol. 314 (8152), 1129-1130
- https://doi.org/10.1016/s0140-6736(79)92524-8
Abstract
No abstract availableThis publication has 12 references indexed in Scilit:
- Pharmacologic Effects in Man of a Potent, Long-Acting Dopamine Receptor AgonistScience, 1979
- Bromocriptine in Parkinson diseaseNeurology, 1979
- Lergotrile in Parkinson diseaseNeurology, 1979
- Differences in the dopaminergic effects of the ergot derivatives bromocriptine, lisuride and d-LSD as compared with apomorphineEuropean Journal of Pharmacology, 1978
- Lisuride Hydrogen Maleate: Evidence for a Long Lasting Dopaminergic Activity in HumansJournal of Clinical Endocrinology & Metabolism, 1978
- SUCCESS AND PROBLEMS OF LONG-TERM LEVODOPA THERAPY IN PARKINSON'S DISEASEThe Lancet, 1977
- Coffee consumption among psychiatric inpatientsAmerican Journal of Psychiatry, 1976
- Direct dopaminergic action of lisuride hydrogen maleate, an ergot derivative, in miceEuropean Journal of Pharmacology, 1976
- SUSTAINED LEVODOPA THERAPY IN PARKINSONISMThe Lancet, 1973
- Evaluation of safety and efficacy of levodopa in Parkinson's disease and syndromeNeurology, 1972